Neural Circuitry Resilience in Psychotic Disorders: A Multimodal Ultra-High Field Neuroimaging Study
Project Number5I01CX001855-04
Contact PI/Project LeaderPRASAD, KONASALE M
Awardee OrganizationVETERANS HEALTH ADMINISTRATION
Description
Abstract Text
Abstract: Good long-term social outcome of schizophrenia (SZ) subjects is as low as 14%. Because of this,
substantial number of SZ subjects suffer from severe and protracted disability. An important contributing factor
to poor long-term outcome in schizophrenia is cognitive impairments that are resistant to current treatments.
Therefore, it is critical to examine novel mechanisms underlying cognitive impairments to design new treatments.
Recent evidence suggests that brain cortical regions and white matter pathways that connect them adapt to
pathophysiological processes. Such adaptation can mitigate impairments in selected cognitive domains offering
hopes to target selected networks for interventions to improve outcome. Using state-of-art non-invasive
neuroimaging techniques, adaptation between the cortical neuropil (synapses, dendrites and its branches,
axonal endings and interneurons) and white matter integrity measured using characteristics of water diffusion in
white matter fibers can be investigated. The goal of this project is to characterize concurrent changes in cortical
neuropil and anisotropy of water diffusion in white matter fiber tracts as a model of neural circuitry adaptability
(NCA) and its impact on cognitive performance among SZ subjects compared to healthy control subjects (HC).
We will use phosphorus magnetic resonance spectroscopy (31P MRS) at ultra-high magnetic field (7 Tesla) that
provides greater sensitivity to investigate neuropil by measuring membrane phospholipid (MPL) metabolites in
multiple anatomically well-defined regions across the entire brain. MPLs are critical ingredients of neuronal
membranes that naturally form lipid bilayers separating the intra- and extra-cellular environments. During
development and disease, imbalance between synthesis and degradation of membranes can be reliably
captured. Broadly, higher MPL precursor levels are associated with membrane expansion while higher MPL
breakdown products suggest neuropil membrane contraction. Since such dynamic changes are prominently
observed in the neuropil, 31P MRS can provide a more specific measure of neuropil than structural imaging
measures that includes neuropil as well as interneuronal space, microvasculature and neuronal soma. Neurite
Orientation Dispersion and Density Imaging (NODDI) - a state-of-the-art method to measure diffusion of water
along white matter tracts and neurite density- will be used to examine integrity of white matter pathways more
reliably than the older method of diffusion tensor imaging. Innovative nature of this proposal is highlighted by
concurrent changes in MPL metabolites and anisotropy as measures of NCA in relation to cognitive impairments
since using single modality imaging cannot measure adaptive changes in multiple tissues. Using our model of
NCA by employing multi-modal 31P MRS-NODDI data, we seek to examine association of NCA with cognitive
performance across the whole-brain (aim 1). Additionally, factors associated with NCA are unknown. Since SZ
is a highly heritable disorder, and inflammation is associated with SZ, we will examine the contribution of selected
genetic and peripheral inflammatory markers (Interleukin-6, IL6 and C-reactive protein, CRP) to NCA. Our
studies found association of Complement C4A (C4A) gene copy numbers with neuropil changes, and of IL-6 and
CRP levels with alterations in neuropil and white matter anisotropy. Based this evidence, our next aim is to
determine the association of C4A copy numbers and peripheral immune mediator levels with measures of NCA
among SZ and HC (aim 2). Application of integrated state-of-the-art methods to examine a less well understood
concept of NCA in SZ makes this proposal highly unique and can have significant impact on novel treatment
designs. These efforts may allow us to target adaptable tracts for novel interventions such as customized
cognitive enhancement therapies and electrical stimulation strategies using transcranial magnetic stimulation
(TMS) or transcranial direct current stimulation (tDCS) targeted to selected networks.
Public Health Relevance Statement
Public Health Significance
Schizophrenia is a chronic and severely debilitating brain disorder with poor outcome. Treatments are
symptomatic and the causes are unknown. The associated disability and morbidity adds to major public health
burden of severe mental illness. Gaining a greater understanding of the underlying mechanisms associated
with cognitive impairments could lead to identification of novel targets for innovative treatments. The proposed
effort is driven by intriguing data from diffusion tensor imaging and magnetic resonance spectroscopy. The
goal of this proposal to combine these modalities of imaging to understand the neural circuitry resilience –
adaptation of neurons to internal and external changes, among SZ that may modulate cognitive impairments
that contribute significantly to poor outcome. Currently available treatments minimally affect cognitive
impairments. Therefore, the results of this study can potentially help improve long term outcome.
No Sub Projects information available for 5I01CX001855-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5I01CX001855-04
Patents
No Patents information available for 5I01CX001855-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5I01CX001855-04
Clinical Studies
No Clinical Studies information available for 5I01CX001855-04
News and More
Related News Releases
No news release information available for 5I01CX001855-04
History
No Historical information available for 5I01CX001855-04
Similar Projects
No Similar Projects information available for 5I01CX001855-04